Last reviewed · How we verify

NCT03159000

A Research Study of Greater Occipital Nerve Block as a Treatment for Acute Migraine Attacks

Withdrawn Phase 4 Last updated 26 November 2021
What this trial tests

Phase 4 trial testing Saline in Migraine. Withdrawn.

Timeline
1 May 2017
Primary endpoint
31 December 2017
30 June 2018

Quick facts

Lead sponsorThomas Jefferson University
PhasePhase 4
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Start date1 May 2017
Primary completion31 December 2017
Estimated completion30 June 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Thomas Jefferson University

Who can join

Adults 18 to 80, any sex, with Migraine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Several observational studies have shown improvement in episodic migraine with the use of greater occipital nerve block as an acute therapy, and a recent placebo controlled trial did not show a decrease in frequency of episodic or chronic migraine; however, there has never been a placebo controlled trial to investigate the efficacy of GONB as an acute treatment for headache, and there has been no determination of guidelines for selection of patients who would be most likely to respond to GONB. In light of the above, the investigators propose a double-blind, placebo-controlled, randomized trial examining the use of GONB with lidocaine/bupivocaine in patients with an acute episodic migraine. The results of this trial are expected to guide more appropriate therapeutic management of these participants and the optimal use of this procedure. 50 subjects will be entered into this study. This study is being conducted at Thomas Jefferson University only.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Saline

Trials testing the same drug.

Other recruiting trials for Migraine

Currently open trials in the same condition.

Other Thomas Jefferson University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03159000.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing